SmithKline Beecham Sued For Generic Flonase Delay
A union health care plan has filed a proposed class action against SmithKline Beecham Corp. for allegedly stalling the approval of a generic version of Flonase, the drugmaker's blockbuster nasal allergy...To view the full article, register now.
Already a subscriber? Click here to view full article